Painful days in the investment world, a reminder of October '87. It might be time to position some funds into out-of-favor stocks.
ViroPharma Inc. (VPHM), selling at 9.57, seems to be holding up well in somewhat sad market conditions.
ViroPharma Incorporated is a bio pharmaceutical company, which engages in the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings in the United States.
I see some positive characteristics that could signify a favorable move in the stock price, high average daily volume, may close today above its 50 day moving average (9.49), increased fund ownership over the past few weeks, stock at 48% below the 52 week high, low P/E ratio (7) and a reasonable book value of 1.58 have made this company worth looking at.